Development of new Parkinson’s treatments is only possible if everyone is part of the research process. We need your help to push promising research forward.
A Lord’s inquiry supported by Parkinson’s UK has recommended the UK government urgently prioritises funding and support for clinical research.
From exciting research breakthroughs, to running marathons. We’re celebrating all of our community's fantastic achievements this year.
We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
New research has been published that sheds an important light on how the production of a key protein in the brain is controlled This could pave the way for new treatments for a wide range of neurological conditions.
The earlier groundbreaking clinical trial proved inconclusive. So we’re launching a new company tasked with planning a possible new trial.